Lupin

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
2,347.60
15.8 (0.68%)
BSENSE

Mar 25

BSE+NSE Vol: 11.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lupin
Torrent Pharma
Aurobindo Pharma
Sun Pharma.Inds.
Biocon
Dr Reddy's Labs
Zydus Lifesci.
Alkem Lab
Divi's Lab.
Mankind Pharma
Cipla

Why is Lupin Ltd. ?

1
Company has a low Debt to Equity ratio (avg) at 0.10 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 11.42% and Operating profit at 33.60%
3
The company has declared Positive results for the last 3 consecutive quarters
  • ROCE(HY) Highest at 22.22%
  • PBT LESS OI(Q) At Rs 1,833.91 cr has Grown at 43.6% (vs previous 4Q average)
  • NET SALES(Q) Highest at Rs 7,167.52 cr
4
With ROE of 22, it has a Attractive valuation with a 5.5 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 13.47%, its profits have risen by 73.5% ; the PEG ratio of the company is 0.3
5
High Institutional Holdings at 47.08%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Lupin should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Lupin for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Lupin
13.48%
0.57
23.63%
Sensex
-3.52%
-0.27
13.03%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.42%
EBIT Growth (5y)
33.60%
EBIT to Interest (avg)
6.50
Debt to EBITDA (avg)
3.07
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
20.05%
Dividend Payout Ratio
16.70%
Pledged Shares
0
Institutional Holding
47.08%
ROCE (avg)
10.75%
ROE (avg)
9.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
32
Price to Book Value
5.47
EV to EBIT
16.94
EV to EBITDA
14.02
EV to Capital Employed
5.48
EV to Sales
4.10
PEG Ratio
0.29
Dividend Yield
0.51%
ROCE (Latest)
27.93%
ROE (Latest)
22.03%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
ROCE(HY)

Highest at 22.22%

PBT LESS OI(Q)

At Rs 1,833.91 cr has Grown at 43.6% (vs previous 4Q average

NET SALES(Q)

Highest at Rs 7,167.52 cr

PAT(Q)

Highest at Rs 1,506.40 cr.

-6What is not working for the Company
INTEREST(Latest six months)

At Rs 222.57 cr has Grown at 23.06%

DEBT-EQUITY RATIO(HY)

Highest at 0.32 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.84 times

Loading Valuation Snapshot...

Here's what is working for Lupin

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,833.91 cr has Grown at 43.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1,277.48 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 7,167.52 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 1,506.40 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1,506.40 cr has Grown at 39.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1,081.16 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Lupin

Interest - Latest six months
At Rs 222.57 cr has Grown at 23.06%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 0.32 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 3.84 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 114.70 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income